A better way to navigate potential disruption.

Understanding what will happen, and when, is key to managing the impact of patent expiry - both within your own portfolio and in your competitors’. Stay ahead of potential disruption.
Contact Us

Limit surprise, and be ready for change

The impact of patent expiry can be an unsettling prospect. It can change the balance of your portfolio, open up new competition in the form of generics, and shift your market strategy around the world.

Patent intelligence solutions from IQVIA deliver the data and analytics you need. Backed by data on thousands of patent families for both small molecule and biologics, and include in-depth analysis of patents, data exclusivity, and extensions, our team is ready to help you 

  • Find and assess drug patent expires by country
  • Prepare for the entry of generics across markets
  • Track ongoing litigation 
  • Continually model impact scenarios for your brand
 
IQVIA's Unparalleled Data Assets

60K patent families

tracked across 130 countries
IQVIA's Unparalleled Data Assets

2,500+ molecules

Small molecules covered with in-depth analysis of patents, data exclusivity, and extensions
IQVIA's Unparalleled Data Assets

700+ biologics

covered with in-depth analysis of patents, data exclusivity and extensions
IQVIA's Unparalleled Data Assets

34K+ patents extensions

and supplementary protection certificates referenced
IQVIA's Unparalleled Data Assets

8,500+ cases

in litigation analyzed

Ark Patent Intelligence—Worldwide Pharmaceutical Patent Information

Contact Us
Contact Us

Email Us

Interested in learning more about how IQVIA can create solutions to help you drive healthcare forward?

Call Us

We're available during standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.